Patrick G Johnston Centre for Cancer Research: against COVID-19 Hub

Ken Mills' research has focused on improving diagnosis, prognosis and prediction of therapeutic responses for blood cancers at this Hub. Now he is part of a cross-disciplinary research team that is testing whether current drugs can be “repurposed” to treat COVID-19. 2. https://pubmed.ncbi.nlm.nih.gov/32335477/

Connections from

Headquarters: United Kingdom
Funding Status: N/A
Employee Number: N/A
Investment Stage: N/A
Number Of Exists: N/A
Technology: COVID Labs/Universities
Investor Type: N/A
Founded Date: N/A
Industry: COVID R&D
N/A
Register and Claim Ownership